Michael R. Hayden, Director of AbCellera Biologics ABCL, has filed 9 purchases and 0 sales on the open market. The latest trade was on 06/11.

MH

MH

Michael R. Hayden

Director

Company

AbCellera Biologics ABCL

First filing

23/02/13

Trades

40 trades

Buys / sales

9 / 0

12-month net buying

No record

Last trade

06/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ionis PharmaceuticalsIONS	Open-market buy	25/05/01	25/05/02	15,000 sh	$31.86	$477,900	+42.6%
Ionis PharmaceuticalsIONS	Open-market buy	24/12/23	24/12/26	5,000 sh2 trades	$36.22avg.	$181,075	+16.5%
AbCellera BiologicsABCL	Open-market buy	23/09/22	23/09/26	20,000 sh	$4.91	$98,200	+1.5%
AbCellera BiologicsABCL	Open-market buy	23/08/08	23/08/09	30,000 sh	$5.90	$177,000	+2.4%
89 89bio	Open-market buy	22/03/30–23/03/28	23/03/30	87,788 sh4 trades	$12.28avg.	$1,077,963.7	No record